Abstract
INTRODUCTION Transcranial magnetic stimulation (TMS) has gained increasing attention as a potential therapeutic strategy in Alzheimer’s disease (AD). Among factors determining a clinical response, the choice of the stimulation site represents a key point. In this proof of concept study, we prove the feasibility of a tailored TMS targeting approach for AD, which stems from a network-based perspective. Based on functional imaging, the procedure allows to extract individual optimal targets meanwhile accounting for functional variability.
METHODS Single-subject resting-state fMRI was used to extract individual target coordinates of two networks primarily affected in AD, the default mode and the fronto-parietal network. The localization of these targets was compared to that of traditional group-level approaches and tested against varying degrees of TMS focality.
RESULTS The distance between individual fMRI-derived coordinates and traditionally-defined targets was significant for a focality <12mm, but not for >20mm. Comparison with anatomical labels confirmed a lack of 1:1 correspondence between anatomical and functional targets.
DISCUSSION The proposed network-based fMRI-guided TMS approach allows targeting disorder-specific networks meanwhile accounting for inter-individual functional variability in Alzheimer’s disease. This approach might represent a step toward tailored TMS interventions for AD.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT04263194
Funding Statement
This work was supported by a grant from the Italian Ministry of Health awarded to DB, SB and MP (Bando Ricerca Finalizzata 2016, grant number: GR-2016-02364718).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the local ethics committee (CEIOC) of the IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy (Number 35/2018).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Chiara Bagattini, Debora Brignani, Sonia Bonni', Roberto Gasparotti, Michela Pievani (2020): rsfMRI network-based TMS targeting, Mendeley Data, V1
